BriaCell Therapeutics (BCT) Competitors C$4.23 -0.49 (-10.38%) As of 05/23/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock BCT vs. MBX, ONC, IBT, AEZS, GSD, LTY, ACST, REUN, HEM, and NEPTShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include Microbix Biosystems (MBX), Oncolytics Biotech (ONC), IBEX Technologies (IBT), Aeterna Zentaris (AEZS), Devonian Health Group (GSD), Liberty Biopharma (LTY), Acasti Pharma (ACST), Reunion Neuroscience (REUN), Hemostemix (HEM), and Neptune Wellness Solutions (NEPT). These companies are all part of the "biotechnology" industry. BriaCell Therapeutics vs. Microbix Biosystems Oncolytics Biotech IBEX Technologies Aeterna Zentaris Devonian Health Group Liberty Biopharma Acasti Pharma Reunion Neuroscience Hemostemix Neptune Wellness Solutions BriaCell Therapeutics (TSE:BCT) and Microbix Biosystems (TSE:MBX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment, community ranking and earnings. Which has preferable valuation & earnings, BCT or MBX? Microbix Biosystems has higher revenue and earnings than BriaCell Therapeutics. BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/A-C$2.37M-C$1.32-3.19Microbix BiosystemsC$24.42M1.83C$3.39MC$0.0312.95 Is BCT or MBX more profitable? Microbix Biosystems has a net margin of 13.86% compared to BriaCell Therapeutics' net margin of 0.00%. BriaCell Therapeutics' return on equity of 536.29% beat Microbix Biosystems' return on equity.Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A 536.29% -122.71% Microbix Biosystems 13.86%12.65%3.82% Does the media prefer BCT or MBX? In the previous week, Microbix Biosystems had 3 more articles in the media than BriaCell Therapeutics. MarketBeat recorded 3 mentions for Microbix Biosystems and 0 mentions for BriaCell Therapeutics. BriaCell Therapeutics' average media sentiment score of 0.00 beat Microbix Biosystems' score of -1.00 indicating that BriaCell Therapeutics is being referred to more favorably in the media. Company Overall Sentiment BriaCell Therapeutics Neutral Microbix Biosystems Negative Does the MarketBeat Community prefer BCT or MBX? Microbix Biosystems received 69 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 100.00% of users gave BriaCell Therapeutics an outperform vote while only 70.71% of users gave Microbix Biosystems an outperform vote. CompanyUnderperformOutperformBriaCell TherapeuticsOutperform Votes1100.00% Underperform VotesNo VotesMicrobix BiosystemsOutperform Votes7070.71% Underperform Votes2929.29% Do insiders and institutionals believe in BCT or MBX? 15.0% of BriaCell Therapeutics shares are held by institutional investors. Comparatively, 0.4% of Microbix Biosystems shares are held by institutional investors. 9.3% of BriaCell Therapeutics shares are held by insiders. Comparatively, 14.0% of Microbix Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, BCT or MBX? BriaCell Therapeutics has a beta of 1.83, suggesting that its stock price is 83% more volatile than the S&P 500. Comparatively, Microbix Biosystems has a beta of 0.34, suggesting that its stock price is 66% less volatile than the S&P 500. SummaryMicrobix Biosystems beats BriaCell Therapeutics on 9 of the 14 factors compared between the two stocks. Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart BCT vs. The Competition Export to ExcelMetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$10.91MC$128.95MC$5.34BC$5.95BDividend Yield13.70%3.74%5.27%6.32%P/E Ratio-3.193.4726.9629.48Price / SalesN/A4,168.74399.08926.00Price / CashN/A13.1938.3283.44Price / Book20.5433.216.774.01Net Income-C$2.37M-C$91.56MC$3.24BC$301.20M7 Day Performance3.68%2.92%0.26%1.00%1 Month Performance-49.94%6.96%6.07%5.67%1 Year Performance114.72%102.33%18.46%16.88% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTBriaCell TherapeuticsN/AC$4.23-10.4%N/A+113.6%C$10.91MN/A-3.1916Gap DownMBXMicrobix BiosystemsN/AC$0.34-2.9%N/A+4.6%C$44.78MC$24.42M12.95N/AGap DownONCOncolytics Biotech0.653 of 5 starsC$0.56-3.4%C$3.50+525.0%-62.1%C$43.16MN/A-1.5629News CoverageNegative NewsAnalyst RevisionIBTIBEX TechnologiesN/AC$1.44flatN/A+0.0%C$35.54MC$5.77M11.52N/AAEZSAeterna ZentarisN/AN/AN/AN/AC$25.37MC$2.37M-2.6120GSDDevonian Health GroupN/AC$0.16+3.2%N/A-7.7%C$23.72MC$9.75M-8.006Gap UpLTYLiberty BiopharmaN/AC$2.00+∞N/A+0.0%C$21.54MN/A-12.66N/AGap UpACSTAcasti PharmaN/AC$0.58+1.8%N/A+0.0%C$18.19MC$2.71M-1.2132REUNReunion NeuroscienceN/AN/AN/AN/AC$16.64MC$4.86M-0.43190Gap DownHEMHemostemixN/AC$0.11-15.4%N/A+175.0%C$16.03MN/A-3.21N/ANEPTNeptune Wellness SolutionsN/AN/AN/AN/AC$15.73MC$48.80M-0.08130Gap Down Related Companies and Tools Related Companies MBX Alternatives ONC Alternatives IBT Alternatives AEZS Alternatives GSD Alternatives LTY Alternatives ACST Alternatives REUN Alternatives HEM Alternatives NEPT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:BCT) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Hidden Energy Source Backed by Billionaires Why Billionaires Have Set Their Sights on the Utah Desert Something strange is happening near the Wah Wah ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCT Stock Free BCT Stock Alerts